Literature DB >> 9401539

Prader-Willi syndrome and the hypothalamus.

D F Swaab1.   

Abstract

Dysfunction of various hypothalamic systems may be the basis of a number of symptoms in Prader-Willi syndrome. The often abnormal position of the baby in the uterus at the onset of labour, the high percentage of infants with asphyxia and the high proportion of children born prematurely or post-maturely may all be related to abnormal fetal hypothalamic systems, as the fetal hypothalamus plays a crucial role in labour. Abnormal luteinizing hormone-releasing hormone neurones are thought to be responsible for the decreased levels of sex hormones, resulting in non-descended testes, undersized sex organs and insufficient growth during puberty. A lack of growth hormone-releasing hormone may also contribute to the short stature of patients with Prader-Willi syndrome. In addition, the aberrant control of body temperature and daytime hypersomnolence may result from hypothalamic disturbances. The number of oxytocin neurones--the putative satiety neurones--in the hypothalamic paraventricular nucleus is markedly decreased in Prader-Willi syndrome. This is presumed to be the basis of the insatiable hunger and obesity of patients with the syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401539     DOI: 10.1111/j.1651-2227.1997.tb18369.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  45 in total

1.  Hypothalamic expression of snoRNA Snord116 is consistent with a link to the hyperphagia and obesity symptoms of Prader-Willi syndrome.

Authors:  Qian Zhang; Gerrit J Bouma; Kristy McClellan; Stuart Tobet
Journal:  Int J Dev Neurosci       Date:  2012-06-01       Impact factor: 2.457

2.  Novel paternally expressed intergenic transcripts at the mouse Prader-Willi/Angelman Syndrome locus.

Authors:  Victoria L Buettner; Andrew M Walker; Judith Singer-Sam
Journal:  Mamm Genome       Date:  2005-04       Impact factor: 2.957

3.  Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.

Authors:  T Cadoudal; M Buléon; C Sengenès; G Diene; F Desneulin; C Molinas; S Eddiry; F Conte-Auriol; D Daviaud; P G P Martin; A Bouloumié; J-P Salles; M Tauber; P Valet
Journal:  Int J Obes (Lond)       Date:  2014-01-10       Impact factor: 5.095

4.  Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors.

Authors:  Marta Pace; Matteo Falappa; Andrea Freschi; Edoardo Balzani; Chiara Berteotti; Viviana Lo Martire; Fatemeh Kaveh; Eivind Hovig; Giovanna Zoccoli; Roberto Amici; Matteo Cerri; Alfonso Urbanucci; Valter Tucci
Journal:  JCI Insight       Date:  2020-06-18

Review 5.  Genomic imprinting in development, growth, behavior and stem cells.

Authors:  Robert N Plasschaert; Marisa S Bartolomei
Journal:  Development       Date:  2014-05       Impact factor: 6.868

6.  Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.

Authors:  G Grugni; G Guzzaloni; F Morabito
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

Review 7.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

8.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Authors:  Lisa C Burnett; Charles A LeDuc; Carlos R Sulsona; Daniel Paull; Richard Rausch; Sanaa Eddiry; Jayne F Martin Carli; Michael V Morabito; Alicja A Skowronski; Gabriela Hubner; Matthew Zimmer; Liheng Wang; Robert Day; Brynn Levy; Ilene Fennoy; Beatrice Dubern; Christine Poitou; Karine Clement; Merlin G Butler; Michael Rosenbaum; Jean Pierre Salles; Maithe Tauber; Daniel J Driscoll; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

9.  Nutritient intake of young children with Prader-Willi syndrome.

Authors:  Marianne Lindmark; Kerstin Trygg; Kaja Giltvedt; Svein O Kolset
Journal:  Food Nutr Res       Date:  2010-03-17       Impact factor: 3.894

10.  SNORD116 and SNORD115 change expression of multiple genes and modify each other's activity.

Authors:  Marina Falaleeva; Justin Surface; Manli Shen; Pierre de la Grange; Stefan Stamm
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.